NCT00347802已完成4 期
Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Single
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •· Male or female > 18 years of age
- •Naive to treatment or washed off any ocular hypotensive agents
- •Untreated IOP >19 mm Hg
- •Diagnosis of open-angle glaucoma or ocular hypertension
- •Ability to provide informed consent and likely to complete study
排除标准
- •· Known contraindication to bimatoprost or travoprost, or any component of any study medication
- •Uncontrolled systemic disease
- •Active ocular disease other than glaucoma or ocular hypertension
- •Required use of ocular medications other than the study medications during the study
- •History of intraocular surgery within the last 3 months
- •Prior discontinuation of any of the study medications for reasons related to efficacy or safety
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)GlaucomaOpen-Angle GlaucomaOcular HypertensionNCT01464424Alcon Research84
已完成
3 期
Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion PressuresGlaucomaNCT02154217University of Milan200
已完成
4 期
24-hour IOP-lowering Effect of 0.01% BimatoprostIntraocular PressureGlaucomaOcular HypertensionNCT01271686University of California, San Diego16
已完成
4 期
24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFGGlaucomaNCT00757835Aristotle University Of Thessaloniki40
已完成
4 期
Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular HypertensionGlaucomaNCT00348023Innovative Medical